Immunic, Inc. SEC filings IMUX
Immunic, Inc. has 832 filings in SEC EDGAR's recent list, going back to Feb 18, 2004. Its latest annual report, Form 10-K, was filed on Feb 26, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | May 29, 2026 | Jun 29, 2026 |
| DEF 14A | Proxy statement | Mar 2, 2026 | Apr 14, 2026 |
| PRE 14A | Preliminary proxy statement | Feb 20, 2026 | Apr 14, 2026 |
| DEFA14A | Additional proxy material | Apr 22, 2025 | — |
| DEF 14A | Proxy statement | Apr 22, 2025 | Jun 4, 2025 |
| DEF 14A | Proxy statement | Apr 23, 2024 | Jun 11, 2024 |
| DEF 14A | Proxy statement | Feb 5, 2024 | Mar 4, 2024 |
| PRE 14A | Preliminary proxy statement | Jan 24, 2024 | Mar 4, 2024 |
| DEF 14A | Proxy statement | May 1, 2023 | Jun 28, 2023 |
| DEF 14A | Proxy statement | Apr 27, 2022 | Jun 15, 2022 |
| DEF 14A | Proxy statement | Apr 27, 2021 | Jun 10, 2021 |
| DEF 14A | Proxy statement | Apr 29, 2020 | Jul 2, 2020 |
| DEF 14A | Proxy statement | Jun 18, 2019 | Jul 16, 2019 |
| DEFA14A | Additional proxy material | Mar 27, 2019 | — |
| DEFA14A | Additional proxy material | Mar 25, 2019 | — |
| DEFA14A | Additional proxy material | Mar 22, 2019 | — |
| DEFA14A | Additional proxy material | Mar 13, 2019 | — |
| DEF 14A | Proxy statement | Apr 12, 2018 | Apr 11, 2018 |
| DEFA14A | Additional proxy material | Apr 12, 2018 | — |
| DEFA14A | Additional proxy material | Apr 11, 2017 | — |
| DEF 14A | Proxy statement | Apr 11, 2017 | Apr 11, 2017 |
| DEFA14A | Additional proxy material | Apr 14, 2016 | — |
| DEF 14A | Proxy statement | Apr 14, 2016 | May 24, 2016 |
| DEFA14A | Additional proxy material | Oct 7, 2015 | — |
| DEF 14A | Proxy statement | Oct 7, 2015 | Nov 17, 2015 |
Showing 25 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- IMUX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, United States
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1280776
- Former names
- VITAL THERAPIES INC (until Apr 10, 2019)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.